Oruka Therapeutics, Inc. · NASDAQ:ORKA
Sandler Laura Lee sold 5,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 1, 2026
On May 1, 2026, Sandler Laura Lee (Chief Operating Officer) sold 5,000 Oruka Therapeutics, Inc. shares at an average US$63.88 for US$319K under a trading plan, leaving 236,984 shares. Filed May 1, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$63.88 average (US$62.58 to US$68.48)
- Value
- US$319K
- Holding after
- 236,984 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Option exercise | 5,000 | US$7.80 | 241,984 | Direct |
| May 1, 2026 | Common Stock | Sale | 2,200 | US$62.58 | 239,784 | Direct |
| May 1, 2026 | Common Stock | Sale | 1,800 | US$64.15 | 237,984 | Direct |
| May 1, 2026 | Common Stock | Sale | 300 | US$65.10 | 237,684 | Direct |
| May 1, 2026 | Common Stock | Sale | 400 | US$66.06 | 237,284 | Direct |
| May 1, 2026 | Common Stock | Sale | 200 | US$67.16 | 237,084 | Direct |
| May 1, 2026 | Common Stock | Sale | 100 | US$68.48 | 236,984 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Sandler Laura Lee
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Sandler Laura Lee · Sep 15, 2026
- Form 4 · Sandler Laura Lee · Sep 1, 2026
- Form 4 · Sandler Laura Lee · Jul 1, 2026
- Form 4 · Sandler Laura Lee · Jun 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026